Harry Gillis
Stock Analyst at Berenberg Bank
(4.59)
# 950
Out of 5,055 analysts
89
Total ratings
72.3%
Success rate
21.8%
Average return
Main Sectors:
Stocks Rated by Harry Gillis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Reiterated: Buy | $140 | $88.66 | +57.91% | 15 | Oct 7, 2026 | |
| SWX: TECN Tecan Group AG | Reiterated: Buy | CHF 240.00 → CHF 300.00 | CHF 247.00 | +21.46% | 15 | Oct 2, 2026 | |
| ETR: FME Fresenius Medical Care AG | Downgraded: Hold | €42.00 | €38.33 | +9.57% | 1 | Sep 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €270.00 → €280.00 | €258.00 | +8.53% | 7 | Sep 11, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $100 | $226.30 | -55.81% | 13 | Sep 10, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $46 | $45.56 | -0.13% | 11 | Sep 10, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 560.00 | kr 437.40 | +28.03% | 27 | Sep 10, 2026 |
BioNTech SE
Oct 7, 2026
Reiterated: Buy
Price Target: $140
Current: $88.66
Upside: +57.91%
Tecan Group AG
Oct 2, 2026
Reiterated: Buy
Price Target: CHF 240.00 → CHF 300.00
Current: CHF 247.00
Upside: +21.46%
Fresenius Medical Care AG
Sep 29, 2026
Downgraded: Hold
Price Target: €42.00
Current: €38.33
Upside: +9.57%
Sartorius Aktiengesellschaft
Sep 11, 2026
Reiterated: Buy
Price Target: €270.00 → €280.00
Current: €258.00
Upside: +8.53%
Moderna
Sep 10, 2026
Reiterated: Hold
Price Target: $45 → $100
Current: $226.30
Upside: -55.81%
Qiagen
Sep 10, 2026
Reiterated: Hold
Price Target: $46
Current: $45.56
Upside: -0.13%
Swedish Orphan Biovitrum AB (publ)
Sep 10, 2026
Reiterated: Buy
Price Target: kr 560.00
Current: kr 437.40
Upside: +28.03%